Funds holding Achilles Therapeutics PLC
ISIN US00449L1026 · United Kingdom · LEI 984500FDESEB1BE52A76
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 2.5K $
A single tracked fund declares this company: these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1,700 | 2.5K $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | 0 | 1,700 | 0.0 % |
| 2026Q1 | 1 | 0 | 1,700 | 0.0 % |
| 2025Q4 | 1 | 0 | 1,700 | 0.0 % |
| 2025Q3 | 1 | -1 | 1,700 | -92.7 % |
| 2025Q2 | 2 | 0 | 23,290 | +7.4 % |
| 2025Q1 | 2 | 0 | 21,690 | 0.0 % |
| 2024Q4 | 2 | 0 | 21,690 | 0.0 % |
| 2024Q3 | 2 | 0 | 21,690 | 0.0 % |
| 2024Q2 | 2 | +1 | 21,690 | +0.5 % |
| 2024Q1 | 1 | 0 | 21,590 | 0.0 % |
| 2023Q4 | 1 | 21,590 |
Institutional managers
3 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Trium Capital LLP | 30,753 | 45.5K $ | as of Mar 31, 2026 |
| RHUMBLINE ADVISERS | 4,480 | 6.6K $ | as of Mar 31, 2026 |
| GAMMA Investing LLC | 806 | 1.2K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding Achilles Therapeutics PLC". https://titelia.com/en/stocks/achilles-therapeutics-plc-US00449L1026